海外の治験の状況「COVID-19」での検索結果
70件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19)
- novel coronavirus pneumonia (COVID-19)
- China
- 2020-01-29
Recruiting
- Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial
- novel coronavirus pneumonia (COVID-19)
- China
- 2020-01-30
Recruiting
- Comparison of efficacy and safety of three antiviral regimens in patients with mild to moderate novel coronavirus pneumonia (COVID-19): a randomized controlled trial
- Novel Coronavirus Pneumonia (COVID-19)
- China
- 2020-01-28
Recruiting
- A randomized, open-label, blank-controlled trial for the efficacy and safety of lopinavir-ritonavir and interferon-alpha 2b in hospitalization patients with novel coronavirus pneumonia (COVID-19)
- Novel Coronavirus Pneumonia (COVID-19)
- China
- 2020-01-23
Recruiting
- CAR-T-19-DNR/ CAR-T-19 clinical study
- Diffuse large b-cell lymphoma
- China
- 2019-06-30
Recruiting
- CART-19 Cells For R/R B-ALL
- Relapsed/Refractory B-cell ALL;Relapsed/Refractory B-cell ALL;Relapsed/Refractory B-cell ALL;Relapsed/Refractory B-cell ALL
- China
- 2017-12-30
Recruiting
- Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL
- Leukemia
- China
- 2016-05-31
Recruiting
- CART-19 Cells For MRD Positive CD19+ ALL
- Acute Lymphoblastic Leukemia;Acute Lymphoblastic Leukemia;Acute Lymphoblastic Leukemia;Acute Lymphoblastic Leukemia
- China
- 2017-01-17
Recruiting
- CART-19 Cells for R/R B-cell Lymphoma
- Relapsed or Refractory B-cell Lymphoma;Relapsed or Refractory B-cell Lymphoma;Relapsed or Refractory B-cell Lymphoma;Relapsed or Refractory B-cell Lymphoma
- China
- 2017-12-30
Recruiting
- Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19
- Type 2 Diabetes Mellitus
- Denmark
- 2019-03-05
